# A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy

> **NCT00861445** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 119 (actual)

## Conditions studied

- Painful Diabetic Neuropathy

## Interventions

- **DRUG:** SPM927/Lacosamide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00861445
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2003-01
- **Final completion:** 2003-02
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2014-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00861445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00861445, "A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00861445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
